Silence the Shame, is set to host a college empowerment summit to provide resources, support and inspiration to college ...

During HUAWEI CONNECT 2024, Huawei Cloud hosted a Summit themed 'One Step to Intelligence, One Leap to Excellence', gathering ...

The state recognized the nonprofit organization for honoring its history and ongoing contributions to the community and the ...

The China-based trial enrolled 398 patients who were randomised to the ivonescimab and Keytruda arms at a one-to-one ratio.

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.